Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-12-02
1994-08-02
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3702, C07K 900
Patent
active
053345835
ABSTRACT:
Described are the use of hexopyranose compounds of the formula I ##STR1## for the prophylaxis and treatment of virus infections, and novel pharmaceutical preparations especially suitable for the use in accordance with the invention.
The substituents in formula I have the meanings given in the claims.
REFERENCES:
patent: 2436699 (1948-07-01), Rose
patent: 2447715 (1948-04-01), Rose
patent: 3663235 (1972-01-01), Menz
patent: 4082735 (1978-06-01), Jones et al.
patent: 4082736 (1978-04-01), Jones et al.
patent: 4119714 (1978-03-01), Kny
patent: 4235792 (1980-07-01), Hsia
patent: 4254115 (1981-09-01), Davidson
patent: 4323560 (1982-09-01), Baschang et al.
patent: 4372949 (1980-12-01), Kodama
patent: 4377570 (1983-03-01), Durette
patent: 4406890 (1983-10-01), Tarcsay et al.
patent: 4409209 (1983-10-01), Baschang
patent: 4414204 (1983-12-01), Tarcsay et al.
patent: 4423038 (1983-02-01), Baschang et al.
patent: 4426330 (1981-10-01), Sears
patent: 4426525 (1981-07-01), Hozumi
patent: 4493832 (1982-04-01), Teraji
patent: 4534899 (1983-03-01), Sears
patent: 4548923 (1983-09-01), Hartmann
patent: 4873322 (1989-10-01), Fechtig
patent: 4885285 (1989-12-01), Baschang
Chem Abst. 66:95388g (1967).
Chem Abst. 69:95890b (1968).
Chem Abst. 71:123473e (1969).
Derwent Abst. of EP 138558 (1985).
Derwent Abst. of JP 52087221 (1977).
Journal of Immunological Methods vol. 65 pp. 295-306 (1983).
Lukas, et al, Archives of Virology, vol. 49 pp. 1-11 (1975).
Stedman's Medical Dictionary 1976 p. 1559 23rd Ed.
Avery's Drug Treatment, 3rd Ed. pp. 1230-1249 1987.
J. of Interferon Research 9:275-283 (1989) Gangemi, et al.
Merck Manual of Diagnosis & Therapy 15th Ed. 158-186 (1987).
Microbiology Including Immunology and Molecular Genetics 3rd Ed. 1003-1013 (Harper & Row 1980).
Lukas Bohumir
Ruppin Karl H. S.
Ciba-Geigy Corp.
Fishman Irving M.
Kaiser Karen G.
Lee Lester L.
LandOfFree
Use of sugar derivatives for the prophylaxis and treatment of vi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of sugar derivatives for the prophylaxis and treatment of vi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sugar derivatives for the prophylaxis and treatment of vi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-64936